Connected data gives you a clearer picture
At Evaluate we collect, calibrate and connect the pharmaceutical world's data.
Press Releases
Welcome to our press release archive. To learn more about how we work with healthcare and business reporters worldwide, or if you are looking for specific data and expert insights to support a current story, please contact us at [email protected].
Latest Press Releases
Evaluate launches CDMO Intelligence solution to support rapidly expanding pharmaceutical CDMO market
Competitive analysis, business development and manufacturing intelligence tool aids complex decision making for CDMOs
Evaluate and Galen Growth Partner to Bring HealthTech Alpha’s Leading Digital Health Data and Insights to Market
Evaluate will be the exclusive reseller of HealthTech Alpha across the globe
Evaluate Expands its Competitive Intelligence Practice
New capabilities greatly enhance Evaluate’s Competitive Intelligence Practice by combining best-in-class R&D, clinical and commercialisation intelligence with expert…
Browse the archive
Worldwide Orphan Drug Sales Are Forecast To Grow At A Cagr Of 11.3% From 2018 To 2024, Double The Rate Forecast For The Non-Orphan Drug Market
Annual “EvaluatePharma Orphan Drug 2018 Report” sees Orphan drugs capture a fifth of worldwide prescription sales by 2024 as sales grow to $262bn.
Fast Pace Of Drug And Device Approvals In 2017 Signals Wider Sector Health For Biopharma But Medtech Companies Struggle
EP Vantage releases its annual analysis of sector performance: Pharma, Biotech and Medtech 2017 in Review.
Uptick In M&A Activity And Investor Cash Expected To Re-Invigorate Pharma And Biotech In 2018
EP Vantage’s Annual Pharma and Biotech Preview explores what’s in store for 2018.
Worldwide Medtech Sales Forecast To Reach $522 Billion By 2022 With A Cagr Of 5.1% Between 2016 And 2022
EvaluateMedTech Report Launches in Conjunction with The MedTech Conference.
Biopharma Stages A Strong Recovery Over The First Half Even As M&A Deals Disappoint, While Unprecedented Amounts Of Money Flow In Medtech But Not Towards Smaller Innovators
EP Vantage Releases Half-Year Reviews of Pharma & Biotech and Medtech Performance.
Japanese Pharmaceutical Market Set To Grow 3.3% (Cagr) Between 2017 And 2022, Significantly Lower Than The Worldwide Outlook (6.5% Cagr)
Latest growth forecasts show optimism surrounding new therapies coming to market counterbalanced by more stringent pricing policy enforcement.
Epi Analyzer: Blockbusters Out, Highly Targeted Therapies In
New Case Studies Highlight Niche Patient Population Identification and Analysis for Enhanced Portfolio Decision-making Using Evaluate’s Epi Analyzer
Pricing Pressure Causes Worldwide Drug Sales Forecasts To Fall For First Time In 10 Years
Fall comes as average cost of developing new drugs totals $4bn over the last 10 years.
Worldwide Prescription Drug Sales to Top Trillion Dollar Mark in 2022 with 32% of the 2022 Increase in Sales to Come From Orphan Drugs
Annual Pharma & Biotech World Preview Report to Launch at Bio 2017